Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiography, Interventional | 8 | 2019 | 1095 | 2.080 |
Why?
|
Lung | 26 | 2021 | 9826 | 1.700 |
Why?
|
Tomography, X-Ray Computed | 41 | 2021 | 20086 | 1.470 |
Why?
|
Lung Neoplasms | 31 | 2021 | 13019 | 1.460 |
Why?
|
Radiography, Thoracic | 14 | 2021 | 1265 | 1.130 |
Why?
|
Biopsy, Needle | 5 | 2021 | 1640 | 1.100 |
Why?
|
Multiple Pulmonary Nodules | 3 | 2019 | 153 | 1.100 |
Why?
|
Hemoptysis | 5 | 2019 | 155 | 0.900 |
Why?
|
Lung Diseases | 6 | 2021 | 1884 | 0.760 |
Why?
|
Catheter Ablation | 8 | 2015 | 2746 | 0.660 |
Why?
|
Lung Diseases, Interstitial | 6 | 2021 | 807 | 0.590 |
Why?
|
Cryosurgery | 2 | 2012 | 453 | 0.580 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2019 | 273 | 0.570 |
Why?
|
Fiducial Markers | 1 | 2017 | 136 | 0.530 |
Why?
|
Dyspnea | 4 | 2021 | 1298 | 0.530 |
Why?
|
Cough | 2 | 2020 | 555 | 0.520 |
Why?
|
Idiopathic Pulmonary Fibrosis | 4 | 2021 | 451 | 0.480 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2017 | 265 | 0.470 |
Why?
|
Radiation Dosage | 7 | 2021 | 1927 | 0.420 |
Why?
|
Lymphatic Diseases | 2 | 2012 | 324 | 0.410 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 6 | 2018 | 5171 | 0.400 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 959 | 0.390 |
Why?
|
Microwaves | 1 | 2012 | 191 | 0.390 |
Why?
|
Positron-Emission Tomography | 4 | 2018 | 6259 | 0.380 |
Why?
|
Thoracic Diseases | 1 | 2012 | 97 | 0.380 |
Why?
|
Tuberous Sclerosis | 3 | 2013 | 1029 | 0.350 |
Why?
|
Preoperative Care | 1 | 2017 | 2245 | 0.310 |
Why?
|
Tracheal Diseases | 1 | 2009 | 113 | 0.310 |
Why?
|
Diagnosis, Differential | 19 | 2021 | 12958 | 0.310 |
Why?
|
Lung Diseases, Parasitic | 1 | 2007 | 14 | 0.310 |
Why?
|
Pneumothorax | 3 | 2019 | 379 | 0.310 |
Why?
|
Fluorodeoxyglucose F18 | 4 | 2013 | 2013 | 0.290 |
Why?
|
Babesiosis | 1 | 2007 | 90 | 0.280 |
Why?
|
Middle Aged | 50 | 2021 | 213127 | 0.270 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2017 | 1183 | 0.270 |
Why?
|
Hemorrhage | 2 | 2015 | 3461 | 0.270 |
Why?
|
Hypertension, Pulmonary | 2 | 2015 | 1527 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 3236 | 0.260 |
Why?
|
Radiopharmaceuticals | 3 | 2013 | 2658 | 0.260 |
Why?
|
Sensitivity and Specificity | 8 | 2019 | 14720 | 0.240 |
Why?
|
Airway Obstruction | 1 | 2009 | 663 | 0.230 |
Why?
|
Radiographic Image Enhancement | 3 | 2018 | 885 | 0.230 |
Why?
|
Retrospective Studies | 23 | 2021 | 77098 | 0.210 |
Why?
|
Biopsy, Fine-Needle | 2 | 2019 | 1093 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
Aged | 35 | 2021 | 162944 | 0.210 |
Why?
|
Aged, 80 and over | 20 | 2021 | 57683 | 0.210 |
Why?
|
Humans | 77 | 2021 | 742088 | 0.210 |
Why?
|
Male | 56 | 2021 | 349538 | 0.200 |
Why?
|
Iopamidol | 5 | 2014 | 191 | 0.200 |
Why?
|
Pulmonary Fibrosis | 3 | 2018 | 526 | 0.200 |
Why?
|
Thoracic Neoplasms | 1 | 2004 | 268 | 0.200 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 2021 | 29 | 0.200 |
Why?
|
Hemosiderosis | 1 | 2021 | 71 | 0.190 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 66 | 0.190 |
Why?
|
Early Detection of Cancer | 3 | 2020 | 3070 | 0.190 |
Why?
|
Female | 49 | 2021 | 379592 | 0.190 |
Why?
|
Neuroendocrine Cells | 1 | 2021 | 61 | 0.180 |
Why?
|
Hemothorax | 1 | 2019 | 59 | 0.180 |
Why?
|
Biopsy | 6 | 2021 | 6756 | 0.180 |
Why?
|
Chest Tubes | 1 | 2019 | 150 | 0.170 |
Why?
|
Tomography, Optical Coherence | 3 | 2021 | 2637 | 0.170 |
Why?
|
Retroperitoneal Fibrosis | 1 | 2018 | 37 | 0.160 |
Why?
|
Influenza, Human | 3 | 2021 | 1472 | 0.160 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2012 | 654 | 0.160 |
Why?
|
Lymph Nodes | 1 | 2010 | 3465 | 0.160 |
Why?
|
Feasibility Studies | 2 | 2019 | 5062 | 0.160 |
Why?
|
Prednisone | 2 | 2021 | 1567 | 0.150 |
Why?
|
Thoracic Wall | 1 | 2019 | 201 | 0.150 |
Why?
|
Embolism, Air | 1 | 2017 | 111 | 0.150 |
Why?
|
Observer Variation | 6 | 2021 | 2593 | 0.150 |
Why?
|
Ribonucleoproteins | 1 | 2019 | 381 | 0.140 |
Why?
|
Wireless Technology | 1 | 2017 | 99 | 0.140 |
Why?
|
Lymphatic Metastasis | 1 | 2004 | 2906 | 0.140 |
Why?
|
Bronchoscopy | 1 | 2021 | 860 | 0.140 |
Why?
|
Pulmonary Embolism | 2 | 2010 | 2370 | 0.130 |
Why?
|
Temporal Arteries | 1 | 2017 | 128 | 0.130 |
Why?
|
Pulmonary Eosinophilia | 1 | 2016 | 82 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2018 | 9185 | 0.130 |
Why?
|
Fever | 5 | 2016 | 1612 | 0.130 |
Why?
|
Reproducibility of Results | 7 | 2021 | 19862 | 0.130 |
Why?
|
Pulmonary Artery | 2 | 2016 | 1911 | 0.130 |
Why?
|
Tomography, Emission-Computed | 2 | 2011 | 1144 | 0.130 |
Why?
|
Preoperative Period | 1 | 2017 | 546 | 0.120 |
Why?
|
Vasculitis | 2 | 2017 | 521 | 0.120 |
Why?
|
Neoplasm Staging | 7 | 2018 | 11001 | 0.120 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7276 | 0.120 |
Why?
|
Glucocorticoids | 2 | 2021 | 2107 | 0.120 |
Why?
|
Hyperplasia | 2 | 2021 | 1183 | 0.120 |
Why?
|
Organometallic Compounds | 1 | 2018 | 665 | 0.120 |
Why?
|
Heart Arrest | 1 | 2004 | 1469 | 0.120 |
Why?
|
Bronchoalveolar Lavage | 1 | 2014 | 120 | 0.120 |
Why?
|
Precancerous Conditions | 1 | 2021 | 971 | 0.120 |
Why?
|
Aneurysm, False | 1 | 2016 | 276 | 0.120 |
Why?
|
Contrast Media | 7 | 2019 | 5295 | 0.120 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2019 | 8925 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 962 | 0.110 |
Why?
|
Gadolinium | 1 | 2018 | 951 | 0.110 |
Why?
|
Thymus Neoplasms | 1 | 2015 | 268 | 0.110 |
Why?
|
Adult | 26 | 2021 | 213712 | 0.110 |
Why?
|
Calcinosis | 1 | 2021 | 1497 | 0.110 |
Why?
|
Mediastinal Neoplasms | 1 | 2015 | 421 | 0.110 |
Why?
|
Immune Reconstitution Inflammatory Syndrome | 1 | 2012 | 66 | 0.100 |
Why?
|
Ferric Compounds | 1 | 2013 | 374 | 0.100 |
Why?
|
Breast Diseases | 1 | 2015 | 443 | 0.100 |
Why?
|
Geriatric Assessment | 1 | 2019 | 1369 | 0.100 |
Why?
|
Point-of-Care Systems | 2 | 2017 | 1175 | 0.100 |
Why?
|
Chi-Square Distribution | 3 | 2013 | 3510 | 0.100 |
Why?
|
Autoantibodies | 1 | 2019 | 2036 | 0.100 |
Why?
|
Pleural Effusion | 1 | 2014 | 338 | 0.100 |
Why?
|
Pulmonary Infarction | 1 | 2010 | 9 | 0.100 |
Why?
|
Respiratory Function Tests | 2 | 2012 | 1613 | 0.090 |
Why?
|
Lymphangitis | 1 | 2010 | 12 | 0.090 |
Why?
|
Hermanski-Pudlak Syndrome | 1 | 2009 | 22 | 0.090 |
Why?
|
Incidental Findings | 1 | 2015 | 688 | 0.090 |
Why?
|
Bronchial Fistula | 1 | 2010 | 85 | 0.090 |
Why?
|
Vascular Diseases | 1 | 2018 | 1155 | 0.090 |
Why?
|
Patient Selection | 2 | 2012 | 4214 | 0.090 |
Why?
|
Pleural Diseases | 1 | 2010 | 139 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2018 | 1575 | 0.080 |
Why?
|
Disease Progression | 3 | 2019 | 13256 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4839 | 0.080 |
Why?
|
Anticoagulants | 1 | 2004 | 4595 | 0.080 |
Why?
|
Immunoglobulin G | 2 | 2018 | 4554 | 0.080 |
Why?
|
Skin Diseases | 1 | 2017 | 1065 | 0.080 |
Why?
|
Mediastinal Diseases | 1 | 2008 | 89 | 0.080 |
Why?
|
Radiography | 6 | 2011 | 7010 | 0.080 |
Why?
|
Thymus Gland | 1 | 2013 | 1264 | 0.080 |
Why?
|
Papilloma | 1 | 2009 | 148 | 0.080 |
Why?
|
Tracheal Neoplasms | 1 | 2009 | 124 | 0.080 |
Why?
|
Conscious Sedation | 1 | 2012 | 528 | 0.080 |
Why?
|
Oseltamivir | 1 | 2008 | 75 | 0.080 |
Why?
|
Intensive Care Units | 2 | 2019 | 3679 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2723 | 0.080 |
Why?
|
Antiprotozoal Agents | 1 | 2007 | 86 | 0.070 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2009 | 210 | 0.070 |
Why?
|
Rare Diseases | 1 | 2012 | 554 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2013 | 933 | 0.070 |
Why?
|
Tracheal Stenosis | 1 | 2009 | 226 | 0.070 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2008 | 286 | 0.070 |
Why?
|
Positive-Pressure Respiration | 1 | 2010 | 632 | 0.070 |
Why?
|
Vascular Neoplasms | 1 | 2007 | 175 | 0.070 |
Why?
|
Radiosurgery | 1 | 2015 | 1309 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 457 | 0.070 |
Why?
|
Treatment Outcome | 9 | 2021 | 62966 | 0.070 |
Why?
|
Carcinoma | 2 | 2010 | 2374 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2012 | 2372 | 0.060 |
Why?
|
Acute Disease | 1 | 2015 | 7141 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 4 | 2018 | 35342 | 0.060 |
Why?
|
Postoperative Complications | 3 | 2013 | 15244 | 0.060 |
Why?
|
Cohort Studies | 6 | 2019 | 40450 | 0.060 |
Why?
|
Pneumonectomy | 1 | 2011 | 1093 | 0.060 |
Why?
|
Pneumonia | 3 | 2010 | 2117 | 0.060 |
Why?
|
Amyloidosis | 1 | 2010 | 795 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 3760 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 2 | 2013 | 2842 | 0.050 |
Why?
|
Trachea | 1 | 2009 | 1075 | 0.050 |
Why?
|
Societies, Medical | 3 | 2021 | 3740 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15194 | 0.050 |
Why?
|
Mediastinum | 1 | 2004 | 267 | 0.050 |
Why?
|
Nanoparticles | 1 | 2013 | 1902 | 0.050 |
Why?
|
Artifacts | 3 | 2019 | 1903 | 0.050 |
Why?
|
Lymphoma | 2 | 2015 | 1873 | 0.050 |
Why?
|
Lymphoma, B-Cell | 1 | 2007 | 930 | 0.050 |
Why?
|
Pilot Projects | 4 | 2018 | 8297 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8328 | 0.050 |
Why?
|
Myocardium | 1 | 2013 | 4775 | 0.040 |
Why?
|
Rotation | 1 | 2021 | 523 | 0.040 |
Why?
|
Anesthesia | 1 | 2011 | 1548 | 0.040 |
Why?
|
Ankle Injuries | 1 | 2004 | 331 | 0.040 |
Why?
|
Program Evaluation | 2 | 2020 | 2485 | 0.040 |
Why?
|
Lung Transplantation | 1 | 2008 | 1155 | 0.040 |
Why?
|
Algorithms | 3 | 2018 | 13853 | 0.040 |
Why?
|
Pleural Neoplasms | 1 | 2004 | 607 | 0.040 |
Why?
|
Prospective Studies | 6 | 2021 | 53187 | 0.040 |
Why?
|
Retroperitoneal Space | 1 | 2018 | 172 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3507 | 0.040 |
Why?
|
Physical Exertion | 1 | 2021 | 695 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2010 | 2099 | 0.040 |
Why?
|
Massachusetts | 2 | 2021 | 8662 | 0.040 |
Why?
|
Mesothelioma | 1 | 2004 | 818 | 0.040 |
Why?
|
Young Adult | 7 | 2021 | 56350 | 0.040 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2007 | 1377 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2021 | 924 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2020 | 559 | 0.040 |
Why?
|
Hypergammaglobulinemia | 1 | 2017 | 74 | 0.040 |
Why?
|
Iodine | 1 | 2019 | 285 | 0.040 |
Why?
|
Sweating | 1 | 2017 | 123 | 0.040 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2004 | 974 | 0.030 |
Why?
|
Acute Kidney Injury | 2 | 2009 | 1967 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 2 | 2012 | 2557 | 0.030 |
Why?
|
HIV Infections | 2 | 2012 | 16678 | 0.030 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2016 | 61 | 0.030 |
Why?
|
Antiviral Agents | 1 | 2008 | 2978 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2013 | 2885 | 0.030 |
Why?
|
Reference Standards | 1 | 2018 | 1020 | 0.030 |
Why?
|
Venous Thrombosis | 1 | 2004 | 1237 | 0.030 |
Why?
|
Risk Factors | 2 | 2019 | 72145 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1653 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2004 | 2156 | 0.030 |
Why?
|
Program Development | 1 | 2020 | 1314 | 0.030 |
Why?
|
Bronchi | 1 | 2018 | 840 | 0.030 |
Why?
|
Esophageal Neoplasms | 1 | 2004 | 1581 | 0.030 |
Why?
|
Rheumatology | 1 | 2019 | 576 | 0.030 |
Why?
|
Click Chemistry | 1 | 2013 | 95 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2009 | 4029 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3339 | 0.030 |
Why?
|
Prescriptions | 1 | 2015 | 387 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2004 | 2643 | 0.030 |
Why?
|
Adolescent | 4 | 2015 | 85649 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15056 | 0.030 |
Why?
|
Fractures, Bone | 1 | 2004 | 1945 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2015 | 395 | 0.030 |
Why?
|
Patient Admission | 1 | 2019 | 1380 | 0.030 |
Why?
|
Body Fat Distribution | 1 | 2013 | 244 | 0.030 |
Why?
|
Angiomyolipoma | 1 | 2013 | 186 | 0.030 |
Why?
|
Abdominal Neoplasms | 1 | 2013 | 290 | 0.020 |
Why?
|
Mutation | 3 | 2013 | 29717 | 0.020 |
Why?
|
Echocardiography | 1 | 2004 | 5097 | 0.020 |
Why?
|
Respiratory Insufficiency | 2 | 2009 | 1199 | 0.020 |
Why?
|
Genes, erbB-1 | 1 | 2011 | 161 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3528 | 0.020 |
Why?
|
Electrocardiography | 1 | 2004 | 6440 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 2935 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1589 | 0.020 |
Why?
|
Recurrence | 2 | 2016 | 8333 | 0.020 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 484 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2011 | 8829 | 0.020 |
Why?
|
Cadaver | 1 | 2014 | 1333 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2009 | 69 | 0.020 |
Why?
|
Medical Records | 1 | 2015 | 1413 | 0.020 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2010 | 63 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2680 | 0.020 |
Why?
|
Tick-Borne Diseases | 1 | 2009 | 34 | 0.020 |
Why?
|
Heart Neoplasms | 1 | 2013 | 374 | 0.020 |
Why?
|
Fatigue | 1 | 2017 | 1526 | 0.020 |
Why?
|
Chronic Disease | 2 | 2016 | 9144 | 0.020 |
Why?
|
Headache | 1 | 2017 | 1219 | 0.020 |
Why?
|
Scapula | 1 | 2010 | 162 | 0.020 |
Why?
|
Antiphospholipid Syndrome | 1 | 2010 | 173 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2009 | 381 | 0.020 |
Why?
|
Puerto Rico | 1 | 2009 | 356 | 0.020 |
Why?
|
Risk Assessment | 3 | 2018 | 23320 | 0.020 |
Why?
|
United States | 3 | 2021 | 69693 | 0.020 |
Why?
|
Research | 1 | 2015 | 1999 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2008 | 440 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2130 | 0.020 |
Why?
|
Optic Neuritis | 1 | 2008 | 166 | 0.020 |
Why?
|
Forecasting | 1 | 2015 | 2948 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15108 | 0.020 |
Why?
|
Urinalysis | 1 | 2008 | 369 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 1162 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2009 | 463 | 0.020 |
Why?
|
Weight Loss | 1 | 2017 | 2604 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2275 | 0.020 |
Why?
|
Palliative Care | 2 | 2010 | 3478 | 0.020 |
Why?
|
Vincristine | 1 | 2007 | 1036 | 0.020 |
Why?
|
Quinazolines | 1 | 2011 | 1355 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2009 | 1849 | 0.020 |
Why?
|
Brain | 1 | 2011 | 26343 | 0.020 |
Why?
|
Mass Screening | 1 | 2020 | 5238 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4029 | 0.020 |
Why?
|
Hypotension | 1 | 2010 | 880 | 0.020 |
Why?
|
Arthralgia | 1 | 2008 | 456 | 0.020 |
Why?
|
Duodenum | 1 | 2007 | 483 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6365 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39004 | 0.010 |
Why?
|
Bacteremia | 1 | 2010 | 962 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2015 | 3527 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2013 | 2585 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10248 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2011 | 2455 | 0.010 |
Why?
|
Health Personnel | 1 | 2015 | 3210 | 0.010 |
Why?
|
Decision Making | 1 | 2015 | 3869 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2007 | 2236 | 0.010 |
Why?
|
Radiology | 1 | 2015 | 2090 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2007 | 802 | 0.010 |
Why?
|
Chest Pain | 1 | 2008 | 1113 | 0.010 |
Why?
|
Doxorubicin | 1 | 2007 | 2215 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2007 | 1269 | 0.010 |
Why?
|
Quality Improvement | 1 | 2015 | 3738 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4187 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 21719 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8077 | 0.010 |
Why?
|
Heart | 1 | 2013 | 4462 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 8969 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2010 | 8621 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2010 | 2522 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2004 | 20774 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7153 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11472 | 0.000 |
Why?
|